Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The use of IL-17 and IL-23 inhibitors in Swedish clinical practice: a register-based analysis
The Swedish Institute of Health Economics (IHE), Lund, Sweden.
The Swedish Institute of Health Economics (IHE), Lund, Sweden.
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Dermatologi och venereologi.ORCID-id: 0000-0002-3858-8474
2023 (Engelska)Ingår i: Dermatology, ISSN 1018-8665, E-ISSN 1421-9832, Vol. 239, nr 2, s. 262-266Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

BACKGROUND: Interleukin (IL) inhibitors have made completely cleared skin achievable for many patients with moderate to severe psoriasis in clinical trial settings. Few observational studies assess treatment response in accordance with treatment goals in guidelines.

OBJECTIVES: The aim of the study was to analyze the treatment response of IL-17/IL-23 inhibitors in clinical practice and the proportions of patients that reach the treatment target of the Psoriasis Area and Severity Index (PASI) < 3 and the Dermatology Life Quality Index (DLQI) ≤5.

METHODS: A longitudinal, observational study based on the Swedish National Registry for Systemic Treatment of Psoriasis, PsoReg. Patients using IL-17/IL-23 inhibitors with assessments of PASI, DLQI, and EQ-5D before (maximum 6 months) and after (3-12 months) initiation of IL-17/IL-23 were included.

RESULTS: In total, 333 patients using IL-17/IL-23 inhibitors were included. Eighty percent (n = 266) received IL-17 inhibitors, and 20% (n = 67) received IL-23 inhibitors. Sixty-six percent of patients reached both PASI <3 and DLQI ≤5, 23% reached one target, and 11% reached none. The mean (SD) PASI, DLQI, and EQ-5D improvements were 6.75 (6.99), 7.14 (7.97), and 0.126 (0.296), respectively. There was no statistically significant difference in outcomes between IL-17 and IL-23 inhibitor treatment groups.

CONCLUSIONS: IL-17/IL-23 inhibitors are effective in clinical practice, but there is still an unmet therapeutic need in moderate to severe psoriasis.

Ort, förlag, år, upplaga, sidor
S. Karger, 2023. Vol. 239, nr 2, s. 262-266
Nyckelord [en]
DLQI, EQ-5D, Interleukin inhibitors, PASI, Psoriasis
Nationell ämneskategori
Dermatologi och venereologi
Forskningsämne
dermatologi och venereologi
Identifikatorer
URN: urn:nbn:se:umu:diva-201766DOI: 10.1159/000528007ISI: 000898408100001PubMedID: 36516805Scopus ID: 2-s2.0-85145581075OAI: oai:DiVA.org:umu-201766DiVA, id: diva2:1720009
Tillgänglig från: 2022-12-16 Skapad: 2022-12-16 Senast uppdaterad: 2023-07-14Bibliografiskt granskad

Open Access i DiVA

fulltext(160 kB)39 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 160 kBChecksumma SHA-512
afd61f62b1309639152144e08bec8d7764fe3f5712f3b5dacab99b6f5e9042b08cb126ef60e1464f4bcee7d0939b45cbebd44bd3c8a26c951149fa6a8937cfd3
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Schmitt-Egenolf, Marcus

Sök vidare i DiVA

Av författaren/redaktören
Schmitt-Egenolf, Marcus
Av organisationen
Dermatologi och venereologi
I samma tidskrift
Dermatology
Dermatologi och venereologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 102 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 277 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf